Ameo Pharma Private Limited
About Ameo Pharma Private Limited
Data last updated:
Ameo Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 28 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110DL2020PTC362452.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nitin Tomar and Rinky Tomar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Unit No. 208 Second Floor Blg – A Lsc Samrat Enclave, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2023, the company reported a revenue of ₹18.4 Lakh, a growth of 87% compared to the previous year. For the same year it recorded a net loss of ₹43,764 (net margin -2.4%) and EBITDA of -₹8,670 (EBITDA margin -0.5%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressUnit No. 208 Second Floor Blg – A Lsc Samrat Enclave, New Delhi, Delhi, India – 110034
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ameo Pharma Private Limited
The main business activity of Ameo Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ameo Pharma Private Limited FY 2023 filings available
Ameo Pharma Private Limited reported revenue of ₹18.4 Lakh (up 87% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Ameo Pharma Private Limited
Revenue rose 87% in the latest year. EBITDA rose 62% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Ameo Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹8,670 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹43,764 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Ameo Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.5% | •••• | •••• | •••• |
| Net Profit Margin | -2.4% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ameo Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ameo Pharma Private Limited
Ameo Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Oncecare Pharmaceuticals Private Limited | ₹18.41 Lakh (FY 2025) | •••• | •••• | 63.0% | •••• | Jamshedpur, Jharkhand, India |
| Shilpa Buildcon Private Limited | ₹18.41 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Wwso Multitrade and Services Private Limited | ₹18.41 Lakh (FY 2024) | •••• | •••• | 31.0% | •••• | Bhopal, Madhya Pradesh, India |
| Olis Appliances Private Limited | ₹18.41 Lakh (FY 2020) | •••• | •••• | 12.0% | •••• | Patna, Bihar, India |
| Unicore Biotech Private Limited | ₹18.41 Lakh (FY 2025) | •••• | •••• | -5.0% | •••• | Patna, Bihar, India |
| Ameo Pharma Private Limited this company | ₹18.4 Lakh (FY 2023) | •••• | •••• | 87.0% | •••• | New Delhi, Delhi, India |
| Toqon Gadgets Private Limited | ₹18.4 Lakh (FY 2024) | •••• | •••• | -24.0% | •••• | New Delhi, Delhi, India |
| Jai Bharat Footwears Private Limited | ₹18.4 Lakh (FY 2024) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Sheela Agritech Crop Science Private Limited | ₹18.4 Lakh (FY 2021) | •••• | •••• | -9.0% | •••• | Nagpur, Maharashtra, India |
| Niaa Beauty Private Limited | ₹18.4 Lakh (FY 2024) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Bhallat Commerce Private Limited | ₹18.39 Lakh (FY 2022) | •••• | •••• | -23.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Ameo Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Ameo Pharma Private Limited
Ameo Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Tomar | Director | 01 Dec 2021 | 4 Years 10 Months | Current |
| Rinky Tomar | Director | 01 Dec 2021 | 4 Years 10 Months | Current |
Charges & Borrowings of Ameo Pharma Private Limited
Ameo Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ameo Pharma Private Limited
Employment history and EPFO contributions of people linked to Ameo Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ameo Pharma Private Limited
Ameo Pharma Private Limited has 6 board changes on record since 2020: 2 appointments and 4 cessations. The latest: Arti ceased to be Additional Director on 02 Dec 2021.
Credit Ratings, Litigation & Regulatory Alerts for Ameo Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ameo Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ameo Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ameo Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ameo Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ameo Pharma Private Limited
Ameo Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 28 February 2020 (6+ years old) and is registered under CIN U24110DL2020PTC362452.
Ameo Pharma reported revenue of ₹18.4 Lakh for FY 2023 (up 87% YoY).
Ameo Pharma has 2 current directors:
- Nitin Tomar - Director
- Rinky Tomar - Director
Ameo Pharma reported a net loss of ₹43,764 (net margin -2.4%) and EBITDA of -₹8,670 (EBITDA margin -0.5%) for FY 2023, as per its filed financial statements.
The CIN (Corporate Identification Number) of Ameo Pharma is U24110DL2020PTC362452. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ameo Pharma was incorporated on 28 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ameo Pharma by revenue are Oncecare Pharmaceuticals Private Limited, Shilpa Buildcon Private Limited, Wwso Multitrade and Services Private Limited, Olis Appliances Private Limited, Unicore Biotech Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Arti ceased to be Additional Director on 02 Dec 2021. Bhaskar Yadav ceased to be Additional Director on 02 Dec 2021. Nitin Tomar was appointed as Director on 01 Dec 2021. Ameo Pharma has 6 board changes on record in total.
The registered office of Ameo Pharma is at Unit No. 208 Second Floor Blg – A Lsc Samrat Enclave, New Delhi, Delhi, India – 110034.
Ameo Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Ameo Pharma operates in the chemicals industry, in the manufacturing segment.